Rare vascular tumor

Rare vascular tumors encompass a heterogeneous group of uncommon neoplasms that arise from blood vessels or lymphatic vessels. This category, classified under Orphanet code 211237, serves as a broad grouping that includes various subtypes of vascular tumors that do not fall into the more common categories such as infantile hemangiomas or typical vascular malformations. These tumors can affect virtually any organ system, including the skin, soft tissues, bones, liver, spleen, and other visceral organs. They may present as localized masses, diffuse infiltrative lesions, or multifocal disease depending on the specific subtype. Clinical features vary widely depending on the tumor type, location, and extent of disease. Common presentations include visible or palpable masses, pain, swelling, and functional impairment of affected organs. Some rare vascular tumors can cause consumptive coagulopathy (such as Kasabach-Merritt phenomenon), thrombocytopenia, or other hematologic complications. Certain subtypes may behave in a locally aggressive manner, while others have the potential for metastasis. Treatment approaches depend on the specific tumor subtype and may include surgical resection, pharmacotherapy (such as sirolimus, corticosteroids, or vincristine), embolization, radiation therapy, or a combination of these modalities. Management is ideally coordinated through multidisciplinary teams with expertise in vascular anomalies. Given the rarity and heterogeneity of these tumors, diagnosis often requires specialized histopathological and immunohistochemical evaluation, and treatment decisions are frequently guided by expert consensus rather than large-scale clinical trials.

Common questions about Rare vascular tumor